Gero
Singapore
About Gero
GERO is an AI Drug Discovery company created to solve chronic diseases. To date, Gero has raised approximately $19 million in total capital through a combination of equity rounds and SAFEs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.7M
- Last round: Undisclosed (Jan 2024)
- Website: gero.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/gero-60167 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.